Gina L Griffith1, Anne Kasus-Jacobi2, Megan R Lerner3, H Anne Pereira4. 1. Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States. 2. Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States. 3. Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States. 4. Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States.
Abstract
PURPOSE: The neutrophil-derived granular protein, CAP37, an innate immune system molecule, has antibiotic and immunomodulatory effects on host cells, including corneal epithelial cells. We previously showed that CAP37 modulates corneal epithelial cell migration, adhesion, and proliferation, and that protein kinase C delta (PKCδ) mediates CAP37-induced chemotaxis of these cells. The objective of this study was to investigate the hypothesis that CAP37 facilitates corneal wound healing through the PKC signaling pathway. METHODS: The standard "scratch" assay performed on monolayers of corneal epithelial cells was used to measure the in vitro effect of CAP37 on wound closure. In vivo wound healing in response to CAP37 was measured using a mouse corneal epithelium abrasion model. In vitro and in vivo wound closure were monitored over 48 hours. The PKCδ was visualized during wound closure in cell monolayers and corneal epithelium by immunohistochemistry. The importance of PKCδ in CAP37-induced corneal wound healing was assessed by siRNA. RESULTS: We found that CAP37 accelerated wound closure in vitro and in vivo. Maximal closure occurred with concentrations of CAP37 between 250 and 500 ng/mL. Topical applications on mouse cornea led to re-epithelialization of the cornea by 24 hours. Immunohistochemistry of in vitro and in vivo wounds revealed a local increase of PKCδ along the wound edge in CAP37-treated cell monolayers and corneas, compared to untreated controls. CAP37-induced corneal wound healing was significantly reduced in vivo upon treatment with PKCδ siRNA. CONCLUSIONS: These findings support the hypothesis that CAP37 facilitates corneal wound healing through the activation of PKCδ. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE: The neutrophil-derived granular protein, CAP37, an innate immune system molecule, has antibiotic and immunomodulatory effects on host cells, including corneal epithelial cells. We previously showed that CAP37 modulates corneal epithelial cell migration, adhesion, and proliferation, and that protein kinase C delta (PKCδ) mediates CAP37-induced chemotaxis of these cells. The objective of this study was to investigate the hypothesis that CAP37 facilitates corneal wound healing through the PKC signaling pathway. METHODS: The standard "scratch" assay performed on monolayers of corneal epithelial cells was used to measure the in vitro effect of CAP37 on wound closure. In vivo wound healing in response to CAP37 was measured using a mouse corneal epithelium abrasion model. In vitro and in vivo wound closure were monitored over 48 hours. The PKCδ was visualized during wound closure in cell monolayers and corneal epithelium by immunohistochemistry. The importance of PKCδ in CAP37-induced corneal wound healing was assessed by siRNA. RESULTS: We found that CAP37 accelerated wound closure in vitro and in vivo. Maximal closure occurred with concentrations of CAP37 between 250 and 500 ng/mL. Topical applications on mouse cornea led to re-epithelialization of the cornea by 24 hours. Immunohistochemistry of in vitro and in vivo wounds revealed a local increase of PKCδ along the wound edge in CAP37-treated cell monolayers and corneas, compared to untreated controls. CAP37-induced corneal wound healing was significantly reduced in vivo upon treatment with PKCδ siRNA. CONCLUSIONS: These findings support the hypothesis that CAP37 facilitates corneal wound healing through the activation of PKCδ. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Entities:
Keywords:
antimicrobial proteins; corneal epithelium; corneal wound healing; protein kinase C
Authors: Ling C Huang; Tihomira D Petkova; Rose Y Reins; Rita J Proske; Alison M McDermott Journal: Invest Ophthalmol Vis Sci Date: 2006-06 Impact factor: 4.799
Authors: Marta Carretero; María J Escámez; Marta García; Blanca Duarte; Almudena Holguín; Luisa Retamosa; Jose L Jorcano; Marcela Del Río; Fernando Larcher Journal: J Invest Dermatol Date: 2007-09-13 Impact factor: 8.551
Authors: H Anne Pereira; Xin Ruan; Melva L Gonzalez; Irina Tsyshevskaya-Hoover; James Chodosh Journal: Invest Ophthalmol Vis Sci Date: 2004-12 Impact factor: 4.799
Authors: Yasuhito Hayashi; Mindy K Call; Tai-ichiro Chikama; Hongshan Liu; Eric C Carlson; Yan Sun; Eric Pearlman; James L Funderburgh; George Babcock; Chia-Yang Liu; Yuichi Ohashi; Winston W-Y Kao Journal: J Cell Sci Date: 2010-08-10 Impact factor: 5.285
Authors: Jessie Wang; Abhinav Dey; Adam H Kramer; Yuan Miao; Juan Liu; Lisa Baker; Joel M Friedman; Parimala Nacharaju; Roy S Chuck; Cheng Zhang; David J Sharp Journal: Transl Vis Sci Technol Date: 2021-01-08 Impact factor: 3.283
Authors: Anne Kasus-Jacobi; Craig A Land; Amanda J Stock; Jennifer L Washburn; H Anne Pereira Journal: Invest Ophthalmol Vis Sci Date: 2020-04-09 Impact factor: 4.799